25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1138 24 1252 91 1108 178 1084
ERLYTX 73 2 104 6 73 8 49
GI 167 10 522 20 244 32 195
GU 408 16 835 58 706 100 609
LEUK 163 5 261 17 207 32 195
LUNG 212 8 417 20 244 32 195
LYMPH 423 7 365 34 414 65 396
MELAN 8 0 0 1 12 1 6
MMYEL 112 2 104 13 158 22 134
MULT 46 0 0 1 12 3 18
OTHER 44 0 0 2 24 2 12
Total 2794 74 3860 263 3202 475 2893

25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 214 3 157 19 231 38 231
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 6 1 52 2 24 4 24
LEUK 616 8 417 51 621 107 651
LUNG 371 10 522 43 524 68 414
LYMPH 1 0 0 1 12 1 6
OTHER 17 1 52 2 24 5 30
PEOLC 56 0 0 3 37 3 18
PREV 228 2 104 17 207 29 177
SXQOL 651 17 887 49 597 97 590
Total 2163 42 2191 187 2277 352 2141

25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1138 24 1252 91 1108 178 1084
CCD 214 3 157 19 231 38 231
ERLYTX 75 2 104 6 73 8 49
GI 168 10 522 20 244 32 195
GU 414 17 887 60 731 104 633
LEUK 779 13 678 68 828 139 846
LUNG 583 18 939 63 767 100 609
LYMPH 424 7 365 35 426 66 402
MELAN 8 0 0 1 12 1 6
MMYEL 112 2 104 13 158 22 134
MULT 46 0 0 1 12 3 18
OTHER 61 1 52 4 49 7 43
PEOLC 56 0 0 3 37 3 18
PREV 228 2 104 17 207 29 177
SXQOL 651 17 887 49 597 97 590
Total 4957 116 6051 450 5480 827 5035

25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 702 19 991 66 804 109 664
ERLYTX 53 2 104 6 73 7 43
GI 131 8 417 15 183 26 158
GU 300 11 574 40 487 68 414
LEUK 100 2 104 8 97 15 91
LUNG 135 5 261 14 170 23 140
LYMPH 278 5 261 22 268 41 250
MELAN 8 0 0 1 12 1 6
MMYEL 64 0 0 8 97 12 73
MULT 19 0 0 1 12 2 12
OTHER 44 0 0 2 24 2 12
Total 1834 52 2712 183 2227 306 1863

25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 157 2 104 10 122 27 164
ERLYTX 2 0 0 0 0 0 0
GI 1 0 0 0 0 0 0
GU 6 1 52 2 24 4 24
LEUK 249 3 157 19 231 37 225
LUNG 229 9 470 31 377 49 298
LYMPH 1 0 0 1 12 1 6
OTHER 17 1 52 2 24 5 30
PEOLC 47 0 0 3 37 3 18
PREV 228 2 104 17 207 29 177
SXQOL 475 13 678 37 450 69 420
Total 1412 31 1617 122 1484 224 1362

25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 899 24 1252 85 1035 149 907
CCD 167 2 104 9 110 22 134
ERLYTX 55 2 104 6 73 7 43
GI 143 6 313 16 195 31 189
GU 338 12 626 40 487 71 432
LEUK 352 5 261 27 329 52 317
LUNG 397 14 730 48 584 81 493
LYMPH 279 5 261 23 280 42 256
MELAN 8 0 0 1 12 1 6
MMYEL 64 0 0 8 97 12 73
MULT 41 0 0 3 37 8 49
OTHER 117 1 52 4 49 7 43
PEOLC 50 1 52 3 37 5 30
PREV 228 2 104 17 207 29 177
SXQOL 475 13 678 37 450 69 420
Total 3613 87 4537 327 3982 586 3569

25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 988 21 1096 85 1035 168 1023
ERLYTX 69 1 52 5 61 7 43
GI 97 6 313 12 146 19 116
GU 296 10 522 46 560 73 444
LEUK 133 3 157 15 183 28 170
LUNG 186 8 417 17 207 28 170
LYMPH 352 7 365 34 414 61 371
MMYEL 99 2 104 12 146 21 128
MULT 46 0 0 1 12 3 18
Total 2266 58 3026 227 2764 408 2483

25-OCT-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1896 45 2348 184 2240 310 1887
AFFIL 124 3 157 6 73 10 61
CCOP/NCORP 1226 35 1826 115 1400 210 1278
Non-SWOG 1709 31 1618 143 1741 295 1796
Total 4955 114 5949 448 5454 825 5022

25-OCT-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
OTHER NRGGY026 Endomet, Stage I-IV, Pac/Car w/ HER HYL/PHE 1 E 29-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 1 E 28-SEP-26
OTHER NRGBN003 Mening, Grd II, Observation vs Irradiation 2 E 28-SEP-26
LUNG S1900J MET Amplification: Amivantamab Hyaluronidase 1 N 15-OCT-26
OTHER NRGHN009 HN, RT + HD Cisp vs RT + LD Cisp for SCCHN 1 E 02-OCT-26

25-OCT-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 18
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 9
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 8
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 8
LUNG LUNGMAP NSCLC, Adv, Master 2 6
LUNG S1800E Non-Match: Docetaxel + Ramu +/- Cemiplimab 1 6
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 6
GI S2303 Gas/Esoph/GEJ, Adv, Ram + Pac +/- Nivo 1 5
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
GU A032201 Renal Cell, High-Risk, Pembro+Tiv 1 3
SXQOL NRGCC015 E-Mindfulness After Breast Cancer 1 3
GU S1802 Pros, Stg IV, SST ± Surg/RT to Primary Tum 1 3
GU S1931 RENAL, Stg IV, IO + Nephrectomy. vs IO Only 2 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3
GU S2427 Blad, MIBC, RT + Pembrolizumab 1 3